Cardiovascular Systems, Inc. (NASDAQ:CSII) will be discussing 4Q20 financial results with the investment community.on 4th August 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.csi360.com
Earnings Expectation
Cardiovascular Systems, Inc. is set to announce fourth quarter earning results on Tuesday 4th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CSII to report 4Q20 loss of $ 0.46 per share. For the full year, analysts anticipate top line of $ 232.32 million, while looking forward to loss of $ 0.82 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 280.00 million ~ $ 283.00 million
Click Here For More Historical Outlooks Of Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary OAS, a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions.
